JP2008515770A - レチノイン酸のアミノ、アミノ酸またはペプチド結合体 - Google Patents

レチノイン酸のアミノ、アミノ酸またはペプチド結合体 Download PDF

Info

Publication number
JP2008515770A
JP2008515770A JP2007519691A JP2007519691A JP2008515770A JP 2008515770 A JP2008515770 A JP 2008515770A JP 2007519691 A JP2007519691 A JP 2007519691A JP 2007519691 A JP2007519691 A JP 2007519691A JP 2008515770 A JP2008515770 A JP 2008515770A
Authority
JP
Japan
Prior art keywords
residue
peptide
alkyl
amino acid
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007519691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008515770A5 (enExample
Inventor
ラファエル ボイメル，
ヨヘン クロック，
ユルゲン， エイチ． フォルハルド，
フィリップ， エマニュエル マイラン，
ステファン シュトックリ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of JP2008515770A publication Critical patent/JP2008515770A/ja
Publication of JP2008515770A5 publication Critical patent/JP2008515770A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
JP2007519691A 2004-07-09 2005-07-01 レチノイン酸のアミノ、アミノ酸またはペプチド結合体 Pending JP2008515770A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04016239 2004-07-09
PCT/EP2005/007134 WO2006005455A2 (en) 2004-07-09 2005-07-01 Amino, amino acid or peptide conjugates of retinoic acid

Publications (2)

Publication Number Publication Date
JP2008515770A true JP2008515770A (ja) 2008-05-15
JP2008515770A5 JP2008515770A5 (enExample) 2011-09-29

Family

ID=35062952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007519691A Pending JP2008515770A (ja) 2004-07-09 2005-07-01 レチノイン酸のアミノ、アミノ酸またはペプチド結合体

Country Status (7)

Country Link
US (1) US20070270472A1 (enExample)
EP (1) EP1765773A2 (enExample)
JP (1) JP2008515770A (enExample)
KR (1) KR20070038509A (enExample)
CN (1) CN101048375B (enExample)
BR (1) BRPI0513145A (enExample)
WO (1) WO2006005455A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013028633A (ja) * 2005-12-30 2013-02-07 Revance Therapeutics Inc 局所投与用アルギニンヘテロマー
US8962684B2 (en) 2009-09-29 2015-02-24 Shiseido Company, Ltd. Antioxidant composition
JP2020519622A (ja) * 2017-05-11 2020-07-02 ケアジェン カンパニー, リミテッドCaregen Co., Ltd. イソトレチノインとペプチドの結合体

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2491928A2 (en) * 2007-10-19 2012-08-29 The University of Tokyo Therapeutic agent for vitiligo and method of accelerating pigmentation
CN103327965B (zh) * 2011-01-25 2017-07-18 宝洁公司 脂质体和包含脂质体的个人护理组合物
KR101224809B1 (ko) * 2012-04-24 2013-01-21 주식회사 아이피어리스 레티노산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물
EP2745904B1 (en) 2012-12-21 2015-12-16 Dionex Corporation HILIC/Anion-Exchange/Cation-Exchange Multimodal Media
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
CN105530912B (zh) * 2013-08-15 2018-04-13 玫琳凯有限公司 用于处理皱纹的局部皮肤用组合物
FR3054130B1 (fr) * 2016-07-22 2019-04-26 Syntivia Procede de traitement cosmetique de la peau
EP3630083A4 (en) * 2017-05-23 2021-03-10 The Regents of The University of Michigan DIMETHYL-NONATETRAENYL-TRIMETHYL-CYCLOHEXYL COMPOUNDS AND THEIR USES
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
KR102076178B1 (ko) * 2018-07-18 2020-02-11 주식회사 코리아나화장품 초유 및 오르니틴을 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물
KR20210092483A (ko) 2020-01-16 2021-07-26 맹창남 모발 및 두피상태 개선용 화장료 조성물
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
US11583488B2 (en) 2020-06-01 2023-02-21 The Procter & Gamble Company Method of improving penetration of a vitamin B3 compound into skin
CN117384073A (zh) * 2022-07-11 2024-01-12 南京毓浠医药技术有限公司 一种维a酸醇胺类复合物及其制备方法和应用
CN118121574A (zh) * 2022-12-02 2024-06-04 南京毓浠医药技术有限公司 一种含维a酸组合物及其制备方法和用途
KR20250136628A (ko) 2024-03-08 2025-09-16 주식회사 에이치엔컴퍼니 모발 개선용 화장료 조성물
CN118126119B (zh) * 2024-05-10 2024-08-06 荷本世新(北京)生物科技有限公司 维a酸多肽衍生物及其制备方法和用途

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS544948B1 (enExample) * 1970-02-02 1979-03-12
JPS60146896A (ja) * 1983-12-08 1985-08-02 エフ・ホフマン―ラ　ロシユ　アーゲー 新規なレチノイド類
DE4032187A1 (de) * 1990-10-10 1992-04-16 Gradinger F Hermes Pharma N-retinoyl-l-aminomercapto-verbindungen
JPH0912538A (ja) * 1995-06-26 1997-01-14 Basf Ag ９（ｚ）−レチノイン酸のエステル及びアミド
JP2001039997A (ja) * 1999-07-29 2001-02-13 Lion Corp 安定化されたレチノイン酸類の誘導体、ならびにそれらを含有する外用剤組成物
JP2002509914A (ja) * 1998-03-30 2002-04-02 エルジ ケミカル リミテッド ポリエトキシル化レチンアミド誘導体およびその製造方法
JP2002293746A (ja) * 2001-01-26 2002-10-09 Lion Corp レチノイン酸類またはその誘導体を含有する組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950418A (en) * 1970-02-02 1976-04-13 Hoffmann-La Roche Inc. Vitamin A acid amides
DE2300107C2 (de) * 1973-01-03 1982-03-11 Basf Ag, 6700 Ludwigshafen Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid
US5559149A (en) * 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
EP1159952B1 (en) * 1999-03-02 2009-01-14 Kyowa Hakko Kogyo Co., Ltd. N-Acetylhydroxyproline for improving the moisture retention function of the epidermis
KR100439627B1 (ko) * 2001-06-18 2004-07-12 주식회사 엘지생활건강 피부주름 예방 및 치료용 조성물
ATE385769T1 (de) * 2002-07-25 2008-03-15 Lion Corp Topisches präparat
CN1197847C (zh) * 2002-09-02 2005-04-20 复旦大学 化合物n－全反式维甲酰胺衍生物及其制备方法和应用
KR101045658B1 (ko) * 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS544948B1 (enExample) * 1970-02-02 1979-03-12
JPS60146896A (ja) * 1983-12-08 1985-08-02 エフ・ホフマン―ラ　ロシユ　アーゲー 新規なレチノイド類
DE4032187A1 (de) * 1990-10-10 1992-04-16 Gradinger F Hermes Pharma N-retinoyl-l-aminomercapto-verbindungen
JPH0912538A (ja) * 1995-06-26 1997-01-14 Basf Ag ９（ｚ）−レチノイン酸のエステル及びアミド
JP2002509914A (ja) * 1998-03-30 2002-04-02 エルジ ケミカル リミテッド ポリエトキシル化レチンアミド誘導体およびその製造方法
JP2001039997A (ja) * 1999-07-29 2001-02-13 Lion Corp 安定化されたレチノイン酸類の誘導体、ならびにそれらを含有する外用剤組成物
JP2002293746A (ja) * 2001-01-26 2002-10-09 Lion Corp レチノイン酸類またはその誘導体を含有する組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FRAGRANCE JOURNAL, vol. 32, no. 5, JPN6011017946, May 2004 (2004-05-01), pages 59 - 64, ISSN: 0001891201 *
SHEALY, Y. F. ET AL., J. MED. CHEM., vol. 31, JPN6011017945, 1988, pages 190 - 196, ISSN: 0001891200 *
WILKOFF, L. J., ET AL., CANCER RESEARCH, vol. 36, JPN6011017944, 1976, pages 964 - 972, ISSN: 0001891199 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013028633A (ja) * 2005-12-30 2013-02-07 Revance Therapeutics Inc 局所投与用アルギニンヘテロマー
US8815954B2 (en) 2005-12-30 2014-08-26 Revance Therapeutics, Inc. Arginine heteromers for topical administration
US8962684B2 (en) 2009-09-29 2015-02-24 Shiseido Company, Ltd. Antioxidant composition
JP6018752B2 (ja) * 2009-09-29 2016-11-02 株式会社 資生堂 抗酸化組成物
JP2020519622A (ja) * 2017-05-11 2020-07-02 ケアジェン カンパニー, リミテッドCaregen Co., Ltd. イソトレチノインとペプチドの結合体
JP7016886B2 (ja) 2017-05-11 2022-02-07 ケアジェン カンパニー，リミテッド イソトレチノインとペプチドの結合体
US11351266B2 (en) 2017-05-11 2022-06-07 Caregen Co., Ltd. Conjugate of isotretinoin and peptide
US12005123B2 (en) 2017-05-11 2024-06-11 Caregen Co., Ltd. Conjugate of isotretinoin and peptide

Also Published As

Publication number Publication date
BRPI0513145A (pt) 2008-04-29
WO2006005455A2 (en) 2006-01-19
CN101048375A (zh) 2007-10-03
WO2006005455A3 (en) 2008-02-07
US20070270472A1 (en) 2007-11-22
EP1765773A2 (en) 2007-03-28
KR20070038509A (ko) 2007-04-10
CN101048375B (zh) 2012-12-05

Similar Documents

Publication Publication Date Title
JP2008515770A (ja) レチノイン酸のアミノ、アミノ酸またはペプチド結合体
US20100099727A1 (en) Amino acid and peptide conjugates of arylalkylic acids for cosmetic use
EP1625150B1 (de) Tripeptide und deren derivate für die kosmetische verwendung zur verbesserung der hautstruktur
US8394855B2 (en) Cosmetic compositions
US20100286278A1 (en) Composition comprising an HDAC inhibitor in combination with a retinoid
KR102487937B1 (ko) 10-하이드록시스테아르산을 포함하는 화장품 조성물의 용도
US8129562B2 (en) Carboxylic acid derivatives
KR102704068B1 (ko) Sac 유도체 또는 smc 유도체를 포함하는 피부 각질형성세포 분화 촉진용 조성물
DE10010814A1 (de) Verwendung von 4-Oxoretinol und dessen Derivaten in kosmetischen Zubereitungen

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080605

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110412

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110712

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110720

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110810

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120605